FOR IMMEDIATE RELEASE |
31 MARCH 2015 |
IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, announces that it has today issued 1,552,144 new ordinary shares of 2p each (the "Shares") following the vesting of conditional awards of shares made under the Company's Long-Term Incentive Scheme (the "Scheme") in 2012 (the "2012 Awards").
As a result, the Company today received notification from the following Directors/Persons Discharging Managerial Responsibilities in relation to the acquisition of Shares under the Scheme and subsequent sale, at an aggregate price of 226 pence per share, as set out in the table below.
|
|
|
|
Resultant beneficial interest |
|
Director/PDMR |
Position |
Shares vested |
Shares sold |
Shares |
% |
Alan Aubrey |
Chief Executive Officer |
302,695 |
234,384 |
2,436,848 |
0.45% |
Mike Townend |
Chief Investment Officer |
230,625 |
178,578 |
1,063,070 |
0.20% |
Greg Smith |
Chief Financial Officer |
142,768 |
110,549 |
322,138 |
0.06% |
Angela Leach |
Company Secretary |
109,821 |
109,821 |
215,823 |
0.04% |
In addition, the Company has today received notification from David Baynes, Chief Operating Officer, that he has sold 200,000 shares in the Company at an aggregate price of 226 pence per share. Following the sale, Mr Baynes is beneficially interested in 226,066 shares in the Company representing 0.04%.
An application has been made to the Financial Conduct Authority for admission of the Shares to the premium listing segment of the Official List maintained by the UK Listing Authority and to the London Stock Exchange. It is expected that admission will take place on 7 April 2015.
Following this issue of shares, the Company has 537,965,429 ordinary shares in issue.
For more information, please contact:
IP Group plc |
|
Alan Aubrey, Chief Executive Officer |
+44 (0) 20 7444 0050 |
Vicki Bradley, Communications |
+44 (0) 20 7444 0062 |
FTI Consulting |
|
James Melville-Ross/Simon Conway/ |
+44 (0)20 3727 1000 |
Notes for editors
About IP Group
IP Group is a leading UK intellectual property commercialisation company, developing technology innovations primarily from its research intensive partner universities. The Group offers more than traditional venture capital, providing its companies with access to business building expertise, networks, recruitment and business support.
IP Group's portfolio comprises holdings in around 90 early-stage to mature businesses across the Healthcare, Biotech, Cleantech and Technology sectors. These businesses include Oxford Nanopore Technologies, the DNA sequencing development company, Revolymer, best known for its removable chewing gum, and Xeros, which has received many accolades for its revolutionary clothes washing techniques with a much reduced requirement for water.
For more information, please visit our website at www.ipgroupplc.com.
ENDS